IRM
41
10
CFG
95
2
ADM
47
2
MPC
38
2
STT
62
3
AEP
61
-3
CSCO
64
6
ADT
50
2
L
71
2
AMG
77
3
HPE
75
7
CAT
58
-8
EXPD
51
16
CHRW
82
3
PBI
68
2
IR
58
3
MMC
53
-5
FFIV
47
-3
EMN
56
-2
CL
58
2
IRM
41
10
CFG
95
2
ADM
47
2
MPC
38
2
STT
62
3
AEP
61
-3
CSCO
64
6
ADT
50
2
L
71
2
AMG
77
3
HPE
75
7
CAT
58
-8
EXPD
51
16
CHRW
82
3
PBI
68
2
IR
58
3
MMC
53
-5
FFIV
47
-3
EMN
56
-2
CL
58
2
Financhill
Back

Voya Global Advantage and Premium Opportunity Fund Vs. Nektar Therapeutics Industry Stock Comparison

Buy
65

IGA
Voya Global Advantage and Premium Opportunity Fund

Last Price:
$9.78
Seasonality Move:
0.12%
Sell
46

NKTR
Nektar Therapeutics

Last Price:
$46.82
Seasonality Move:
6.44%
Buy
65
Voya Global Advantage and Premium Opportunity Fund (IGA) is a Buy

Is Voya Global Advantage and Premium Opportunity Fund a Buy, Sell or Hold?

  • The current Voya Global Advantage and Premium Opportunity Fund [IGA] share price is $9.80. The Score for IGA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • IGA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $46.84. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IGA Stock Price Chart

What is Voya Global Advantage and Premium Opportunity Fund's stock price today?

  • The Voya Global Advantage and Premium Opportunity Fund share price today is $9.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IGA is experiencing slight selling pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $46.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

IGA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.03 Buy
Relative Strength Index (14 RSI): 57.29 Buy
Chaikin Money Flow: -10176 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.56 - 9.78) Buy
Bollinger Bands (100): (9.64 - 9.92) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.95 Sell
Relative Strength Index (14 RSI): 38.83 Sell
Chaikin Money Flow: 857593 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.69 - 61.39) Sell
Bollinger Bands (100): (34.99 - 62.73) Sell

IGA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.77 Buy
20-day SMA: 9.72 Buy
50-day SMA: 9.71 Buy
200-day SMA: 9.77 Buy
8-day EMA: 9.76 Buy
20-day EMA: 9.72 Buy
50-day EMA: 9.73 Buy
200-day EMA: 9.71 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.29 Sell
20-day SMA: 55.51 Sell
50-day SMA: 57.37 Sell
200-day SMA: 31.53 Buy
8-day EMA: 49.58 Sell
20-day EMA: 53.48 Sell
50-day EMA: 54.29 Sell
200-day EMA: 38.34 Buy

Voya Global Advantage and Premium Opportunity Fund Earnings Growth & IGA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.

Voya Global Advantage and Premium Opportunity Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):